The Chemist and Druggist Stock Survey 2010 has found that many pharmacists are finding it difficult to stock branded medicines.
This in turn is hurting the health of patients, UK experts have warned. It has emerged that drugs intended for sale in the UK are being exported to take advantage of the exchange rates, forcing patients to wait for long until their prescriptions are filled.
Parkinsons Disease
Parkinson's disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. Symptoms of Parkinson's disease are correctable to an extent.
Advertisement
Some of the drugs that are most difficult to obtain include Parkinson's drug Sinemet, breast cancer drug Femara, schizophrenia medicine Zyprexa and the anti-depressant Cipralexare.
Richard Barker, director general of Association of the British Pharmaceutical Industry said there is a need for urgent action on this front, "Manufacturers have supplied more than enough medicines to satisfy patient demand in the UK but there is still not enough getting through to the front line."
The survey also said that 60% of pharmacists were braced for a worse 2011, while 90% said they spent at least one hour per week trying to find the drugs.
Source: Medindia
The survey also said that 60% of pharmacists were braced for a worse 2011, while 90% said they spent at least one hour per week trying to find the drugs.
Source: Medindia
Parkinson's Disease - Animation
Slide animation on Parkinson disease. It is a progressive movement disorder due to degeneration of nerve cells of the substantia nigra of the brain. The symptoms get worse with time but drugs or surgery can control them. PD cannot be cured.
Advertisement
 Parkinson's Disease - Surgical Treatment - AnimationSlide animation on surgery for Parkinson disease. Surgery is only indicated where drugs fail to control the symptoms of this progressive movement disorder. Surgery cannot cure the disease. | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.